期刊文献+

HBsAb阴性者接种乙肝疫苗后影响HBsAb无或弱应答因素的探讨 被引量:4

Discussion of HBsAb weak or non-response affecting factors after HBsAb negative impact on immunization hepatitis B vaccine
下载PDF
导出
摘要 目的:探讨HBsAb阴性者接种乙肝疫苗后影响HBsAb无或弱应答的因素。方法:乙肝病毒血清标志物(HBV-M)检测,采用ELISA方法;HBV-DNA检测,采用实时荧光定量PCR检测。结果:①4951名高中学生中,88.0%(4356/4951)有乙肝疫苗接种史,城镇学生(99.0%)显著高于农村学生(82.5%)(P<0.01);8.6%(425/4951)血清HBsAg和或HBeAg阳性者,其中369名其父母或祖父母或外祖父母为HBV感染者,占86.8%(369/425);57.0%(2822/4951)血清HBsAb阳性,城镇学生59.9%(985/1642)与农村学生55.5%(1837/3309)无显著性差异(P>0.05);血清HBsAb阴性者1704名,占34.4%(1704/4951)。②4526名血清HBsAg和或HBeAg阴性者进行乙肝疫苗接种1年后,2822名血清HB-sAb阳性者HBsAb仍全阳性,1704名血清HBsAb阴性者87.1%(1485/1704)血清HBsAb阳性;12.9%(219/1704)血清HBsAb仍阴性。③HBsAb阴性者接种1年后HBsAb仍阴性者219名,其中11名HBV-DNA>103copies/ml,占5.0%(11/219);52名102copies/ml<HBV-DNA≤103copies/ml,占23.7%(52/219);156名HBV-DNA≤102copies/ml,占71.3%(156/219)。结论:乙肝疫苗接种无或弱应答是个体内、外部多种因素共同作用的结果,引起乙肝疫苗接种无或弱应答的原因中,内部因素起了决定性作用,遗传因素通过决定特定的免疫应答机制也起着重要作用。 Objective:To explore the HBsAb negative impact on immunization hepatitis B vaccine after HBsAb weak or non - response factors. Methods: HBV - M Detection, by ELISA, HBV - DNA testing, using real - time quantitive PCR analysis. Results:①4951 high school students, 88.0% ( 4356/4951 ) Hepatitis B Vaccination history, urban students ( 99. 0% ) was significantly higher than that of rural students ( 82.5% ) ( P 〈 0. 01 ) ; 8.6% ( 425/4951 ) and serum HBsAg or HBsAg or HBeAg positive, of whom 369 of their parents or grandparents for HBV infection, acconting for 86. 8% (369/425) ;57.0% (2822/ 4951 )HBsAb positive serum, urban students 59. 9% (958/1642) and 55.5% of rural students (1837/3309) there was no significant difference (P 〉 0. 05 );serum HBsAb negative 1704 ,aceonfing for 34. 4% (1704/4951). ②526 seyum HBsAg and or HBseAg negative for hepatitis B vaccination in one year after the 2822 serum HBsAg negative 87. 1% ( 1445/1704 )HBsAb positive serum; 12.9% (219/1704) serum HBsAb still negative. ③HBsAb negative one year after vaccination HBsAb still negative 219,of which 11 HBV - DNA 〉 103 copies/ml, acconting for 5.0% ( 11/219 ). 52 103 copies/ml 〈 HBV - DNA ≤ 10^3 copies/ml, acconting for 23.7% (52/1219) ;156 HBV - DNA≤ 10^2 copies/ml,acconting for 71.3% (156/219). Conclusion:The hepetitis B vaccination is no indvidual or weak response, a number of factors working together,the results of hepatitis B vaccine caused no or weak response of the reasons, internal factors played a decisive role, genetic factors decided by a specific immune response mechanism has also played an important role.
作者 杨俊三
出处 《中国卫生检验杂志》 CAS 2008年第6期1168-1170,共3页 Chinese Journal of Health Laboratory Technology
关键词 乙型肝炎 乙型肝炎疫苗 乙肝病毒表面抗体 无应答 影响因素 Hepatitis B Hepatitis B vaccine Hepatitis B virus antibody Non -response Affecting factor
  • 相关文献

参考文献14

二级参考文献101

  • 1周勇,蔡志坤,张冬娟,潘伟毅,洪青山.乙型肝炎疫苗接种纳入儿童计划免疫后的共性问题[J].中国计划免疫,2004,10(3):142-144. 被引量:5
  • 2邵晓萍,罗耀星,雷仁宇,吴承刚,林永杰,疏俊,陆碧茹.广东省2003年儿童计划免疫接种率调查[J].华南预防医学,2005,31(1):32-34. 被引量:38
  • 3曹惠霖.乙型肝炎的流行状况[J].中国计划免疫,1996,2(2):88-90. 被引量:81
  • 4叶维法 钟振义.肝炎学大典[M].天津:天津科学技术出版社,1995.304.
  • 5郑淑鹏.乙型和丙型肝炎研究的若干进展[J].国外预防医学进展,1992,4:16-17.
  • 6黄文明 陈奇珠 张永成 等.幼儿接种乙肝疫苗后抗-HBs水平的动态分析[J].中华预防医学杂志,1992,(1):61-61.
  • 7Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet, 2000,355: 561-565.
  • 8Coates T, Wilson R, Patrick G, et al. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther, 2001, 23: 392-403.
  • 9Shouval D. Hepatitis B vaccines. J Hepatol, 2003, 39 Suppl 1 : S70-76.
  • 10Hieu NT, Kim KH, Janowicz Z, et al. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Vaccine, 2002, 20:1803-1808.

共引文献261

同被引文献84

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部